
Eur J Cardiothorac Surg
Rudzinski et al.
2021
This publication documents the case of a 70-year-old female with symptomatic severe native aortic regurgitation, acquired dextrocardia, moderate-to-severe secondary mitral regurgitation and prohibitive surgical risk. Six months after treatment with aortic valve replacement, the patient remained symptomatic due to moderate-to-severe secondary mitral regurgitation. The patient was treated with the Carillon therapy which resulted in a significant reduction of mitral regurgitation and uneventful follow-up.
This case illustrates the flexibility of the Carillon implant to be used successfully alongside other therapies and highlights the short user learning curve of the Carillon therapy as the procedure was performed by a cardiac surgeon, not an interventional cardiologist.